‘White hot heat’ is not good for a tech-driven NHS but patients and health profs could be – comment #AI

There's a part of me that's warming to the new Secretary of State for Health, Matt Hancock. At least he has a passion - technology.  So much so, that the health tech sector and techies must be drooling at the prospects. Last week Mr Hancock set out his 'vision for a more tech-driven NHS' at... Continue Reading →

Blog: Why the NIHR Journals Library is important from a patient perspective

NIHR Journals Library Launch 20th June 2013 As promised here's my speaking notes from the launch of the NIHR Journals Library today.  Good to see the Minister, Earl Howe, there (I tweeted his remarks earlier) plus the CMO, Professor Dame Sally Davies, Trish Edwards, Asst Editor from the BMJ etc., Public involvement in UK health research... Continue Reading →

Patient View Report: Pharma industry’s lack of transparency harming reputation with patients

Earlier this week Patient View published the results of its annual tracker of the pharmaceutical industry's reputation among patient groups. The latest study surveyed 600 patient groups (72% of them from Europe). As well as asking patient groups to rank 29 pharmaceutical companies by various indices (such as whether their practices were patient-centred) - Lundbeck... Continue Reading →

Testing, testing: please put Testing Treatments interactive through its paces

With the sort of timing which makes me wonder whether I missed my vocation as a TV scheduler it only seems right that, on the day the House of Commons Science and Technology Select Committee has announced its inquiry into access to clinical trial data, I should ask you to road-test 'TestingTreatments interactive.' 'Testing Treatments interactive' is the... Continue Reading →

Patients need apply – European Medicines Agency (EMA) next steps on clinical trial data

The European Medicines Agency (EMA) has published the note of the conference held in London a few weeks ago, about its plans for proactive publication of clinical trial data. It is now setting up five advisory groups and inviting self-nominations from people to join these.  You will find the following listing of the advisory groups, plus... Continue Reading →

Current Controlled Trials (CCT) appoints new advisory board

Current Controlled Trials (CCT), which aims 'to increase the availability, and promote the exchange, of information about ongoing randomised controlled trials worldwide,' has appointed a new advisory board to help it in its work.  Other than yours truly, the Board includes Ben Goldacre and Paul Wicks (PatientsLikeMe) among its members, and is drawing on international... Continue Reading →

Blog at WordPress.com.

Up ↑

%d bloggers like this: